Cargando…
Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
Reliable entity subtyping is paramount for therapy stratification in lung cancer. Morphological evaluation remains the basis for entity subtyping and directs the application of additional methods such as immunohistochemistry (IHC). The decision of whether to perform IHC for subtyping is subjective,...
Autores principales: | Kriegsmann, Mark, Haag, Christian, Weis, Cleo-Aron, Steinbuss, Georg, Warth, Arne, Zgorzelski, Christiane, Muley, Thomas, Winter, Hauke, Eichhorn, Martin E., Eichhorn, Florian, Kriegsmann, Joerg, Christopolous, Petros, Thomas, Michael, Witzens-Harig, Mathias, Sinn, Peter, von Winterfeld, Moritz, Heussel, Claus Peter, Herth, Felix J. F., Klauschen, Frederick, Stenzinger, Albrecht, Kriegsmann, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352768/ https://www.ncbi.nlm.nih.gov/pubmed/32560475 http://dx.doi.org/10.3390/cancers12061604 |
Ejemplares similares
-
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples
por: Kriegsmann, Katharina, et al.
Publicado: (2021) -
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes
por: Kriegsmann, Mark, et al.
Publicado: (2020) -
Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis
por: Eichhorn, Florian, et al.
Publicado: (2021) -
Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis
por: Blasi, Miriam, et al.
Publicado: (2022) -
Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer
por: Kriegsmann, Mark, et al.
Publicado: (2018)